Nestlé SA Revenue & Financials

Revenue held essentially flat from FY2022 to FY2024 — $100.2 billion, then $101.2 billion, then $102 billion — a pattern that reflects the difference between Nestlé's geographic reach and its organic growth capacity. The company's pricing power held through the 2022-2023 inflation cycle, raising prices across most categories to protect margins. Volume declined in response. By FY2024, the price-volume equation had become a strategic problem: consumers in key markets were trading down to private labels, and several Nestlé categories lost measurable market share. Net income of $10.9 billion on $102 billion in revenue implies a net margin of approximately 10.7%. The market capitalization of $220 billion — roughly 2.2x revenue — is below Nestlé's historical multiple and well below where peers like Unilever trade on a comparable basis. The valuation compression reflects investor uncertainty about the company's ability to return to 4-6% organic growth, which characterized the Schneider era's early years, rather than the sub-2% organic growth of 2023-2024. The Purina acquisition for $10.3 billion in 2001 is the clearest example of Nestlé's capital allocation at its most prescient. Pet food was a fragmented, underbranded category when Nestlé bought Ralston Purina. Two decades of premiumization, humanization of pet care, and demographic shifts toward pet ownership among millennials transformed it into one of the fastest-growing consumer categories in the developed world. Purina now comfortably justifies its purchase price on an annual basis. The Gerber acquisition for $5.5 billion in 2007 and Wyeth Nutrition for $11.85 billion in 2012 positioned Nestlé in infant nutrition, a category with extremely high consumer trust requirements. These acquisitions have performed well in emerging markets where birth rates are higher and where the Nestlé brand carries significant authority. They also created the ongoing reputational exposure around infant formula marketing practices that has followed the company across multiple regulatory regimes.